Clinical Trials

Keywords/SWOG Study Number

Area of Research

Accrual Status

Any

Open

Closed

Limit to SWOG Trials

All Trials

SWOG Trials Only

Show only published studies

Study Type

Treatment

Study Chair

Participating Institution

Phase

Cancer Control Subcommittee

Study Sponsor

FDA Registration Trial

Uses PRO Forms

1033 Results

View

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9032

A Controlled Trial of Cyclosporine As A Chemotherapy-Resistance Modifier in Blast Phase-Chronic Myelogenous Leukemia

Research Committee(s)

Leukemia

Activated

06-01-1992

Closed

03-01-1998

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-9135

A Phase II Trial of Taxol and Granulocyte-Colony Stimulating Factor (G-CSF) in Patients with Pancreatic Adenocarcinoma

Research Committee(s)

Gastrointestinal Cancer

Activated

06-01-1992

Closed

01-15-1993

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9134

A Phase II Trial of Taxol and Granulocyte-Colony Stimulating Factor (G-CSF) in Patients with Advanced Soft-Tissue Sarcoma

Activated

06-01-1992

Closed

06-15-1993

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9122

Evaluation of 5-Fluorouracil By Intermittent Infusion in Combination with Alpha-Interferon for Patients with Advanced Renal Cell Carcinoma, Phase II

Research Committee(s)

Genitourinary Cancer

Activated

06-01-1992

Closed

10-15-1993

Closed

Phase

Accrual

53%

Published

SWOG Clinical Trial Number

SWOG-9138

Evaluation of Fazarabine for Advanced (Stage IV) Non-Small Cell Carcinoma of the Lung, Phase II

Activated

05-15-1992

Closed

07-15-1993

Closed

Phase

Accrual

46%

Published

SWOG Clinical Trial Number

SWOG-9058

A Phase II Trial of Intravenous Vinorelbine (Navelbine®) in Previously Untreated Extensive Small Cell Lung Carcinoma

Research Committee(s)

Lung Cancer

Activated

05-15-1992

Closed

06-01-1995

Closed

Phase

Accrual

SWOG Clinical Trial Number

SWOG-9015

A Randomized Trial of Pre- and Post-Operative Chemotherapy Compared to Surgery Alone for Patients with Operable Non Small Cell Carcinoma of the Lung, Phase III

Research Committee(s)

Lung Cancer

Activated

05-15-1992

Closed

03-15-1994

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9019

A Pilot Study of Chemotherapy Plus Radiation Therapy for Selected IIIb (No Malignant Effusion) Non-Small Cell Lung Cancer

Research Committee(s)

Lung Cancer

Activated

04-15-1992

Closed

12-01-1995

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9051

Pilot Evaluation of Combined Hepatic Chemoembolization and Systemic Chemotherapy with 5-FU and Folinic Acid for Metastatic Adenocarcinoma of the Colon and Rectum, Phase II

Research Committee(s)

Gastrointestinal Cancer

Activated

04-15-1992

Closed

04-01-1995

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9035

Randomized Trial of Adjuvant Immunotherapy with an Allogeneic Melanoma Vaccine for Patients with Intermediate Thickness, Node Negative Malignant Melanoma (T3N0M0), Phase III.

Research Committee(s)

Melanoma

Activated

04-15-1992

Closed

11-15-1996

Closed

Phase

Accrual

SWOG Clinical Trial Number

SWOG-9137

Study of the Safety and Efficacy of Photodynamic Therapy Using Photofrin® (Porfimer Sodium) in the Therapeutic and Prophylactic Management of Transitional Cell Carcinoma of the Bladder

Activated

03-15-1992

Closed

12-01-1993

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9151

Evaluation of Topotecan in Hepatoma, Phase II

Research Committee(s)

Gastrointestinal Cancer

Activated

02-01-1992

Closed

06-15-1993

Closed

Phase

Accrual

14%

SWOG Clinical Trial Number

SWOG-9115 (EST-1192) (INT-0127)

Randomized Study of Standard Chemotherapy vs. STAMP V with Autologous Stem Cell Infusion in Stage IV Poor Prognosis Breast Carcinoma, Phase III, a BMT Study (Intergroup)

Activated

02-01-1992

Closed

01-01-1994

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9139

Adjuvant Therapy of Primary Osteogenic Sarcomas, Phase II

Activated

12-15-1991

Closed

12-01-1996

Closed

Phase

Accrual

66%

Published

SWOG Clinical Trial Number

SWOG-9119

Primary Chemotherapy of Poor Prognosis Soft Tissue Sarcomas, Phase II

Activated

12-15-1991

Closed

06-15-1998

Closed

Phase

Accrual

64%

Published

SWOG Clinical Trial Number

SWOG-9136

Biologic Parameters in Soft Tissue Sarcomas: A Companion Study to Select Southwest Oncology Group Clinical Trials with Soft Tissue Sarcoma Patients

Research Committee(s)

Sarcoma

Activated

12-15-1991

Closed

06-15-1998

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9031

A Double Blind Placebo Controlled Trial of Daunomycin and Cytosine Arabinoside With or Without rhG-CSF in Elderly Patients With Acute Myeloid Leukemia

Research Committee(s)

Leukemia

Activated

11-15-1991

Closed

01-15-1995

Closed

Phase

Accrual

18%

Published

SWOG Clinical Trial Number

SWOG-9118

Chemotherapy with FAMTX in Gastric Cancer or FMTX in Colorectal Cancer: Assessment of Pharmacodynamics with Magnetic Resonance Spectroscopy, Cellular Biochemical Pharmacology, and Cellular Pathology, Phase II

Activated

11-15-1991

Closed

11-15-1995

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9110

A Phase II Evaluation of Didemnin B In Central Nervous System Tumors

Research Committee(s)

Brain Cancer

Activated

11-01-1991

Closed

11-15-1993

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-9060

A Pilot Study Evaluation of Multimodality Treatment of Local Regional Esophageal Carcinoma, Phase II

Research Committee(s)

Gastrointestinal Cancer

Activated

11-01-1991

Closed

03-01-1993